Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer: A multivariate study of 492 cases

Cancer

Volumn 69, Issue 5, 1992, Pages 1224-1234

  Cerezo, Laura ^a   Millan, Isabel ^a   Torre, Alejandro ^a   Aragon, Gregorio ^a   Otero, Jose ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CERVICAL LYMPH NODE; CHILD; FEMALE; HEAD AND NECK CANCER; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NECK DISSECTION; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMAN; LYMPHATIC METASTASIS; MALE; MIDDLE AGE; MULTIVARIATE ANALYSIS; NECK; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0026500970     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.2820690526     Document Type: Article

References (49)

1. The prognostic significance of lymph node involvement in pyriform sinus and supraglottic cancers
2. Prognostic factors for loco/regional control and metastasis and the impact on survival
3. The prognostic significance of metastatic cervical lymph nodes
4. Multidisciplinary treatment of advanced spuamous carcinoma of the head and neck
5. Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer
6. Natural history of neck disease in patients with squamous cell carcinoma of oropharynx and pharyngolarynx
7. The different clinical presentation, behaviour and prognosis of carcinomas originating in the epilarynx and the lower supraglottis
8. Carcinoma of the mobile tongue: Incidence of cervical metastases in early lesions related to method of primary treatment
9. Radiotherapy of lymph node metastases in patients with squamous cell carcinoma of the head and neck region
10. Tumor regression and other prognosticaters in advanced head and neck cancers: A sequel to the RTOG methotrexate study
11. Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy
12. Prognostic factors of neck node metastasis
13. Prognostic factors in cervical lymph node metastasis in upper respiratory and digestive tract carcinomas: Study of 1713 cases during a 15‐year period
14. Nonparametric stimation for incomplete observations
15. Regression models and life tables
16. Treatment of lymph node metastases in head and neck cancer. A radiothera‐peutic approach
17. Analysis of time‐dose factors in clinically positive neck nodes treated with irradiation alone in squamous cell carcinoma of the head and neck
18. Regional outcome in oropharyngeal and pharyngolaryngeal cancer treated with high dose per fraction radiotherapy. Analysis of neck disease response in 1646 cases
19. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts
20. Distant metastases following local control of squamous‐cell carcinoma of the nasopharynx, tonsillar fossa and base of the tongue
21. Frequency and sites of distant metastases in head and neck squamous cell carcinoma. An analysis of 101 cases at autopsy
22. Does node location affect the incidence of distant metastases in head and neck squamous cell carcinoma?
23. Patterns of failure in carcinoma of the nasopharynx: Failure at distant sites
24. Are we making any progress?
25. Predicting the response of head and neck cancers to radiation therapy with a multivariate modelling system: An analysis of the RTOG head and neck registry
26. Importance of primary site in assessing chemotherapy response and 7‐year survival data in advanced squamous‐cell carcinoma of the head and neck treated with initial combination chemotherapy without cisplatin
27. Treatment with preoperative irradiation and surgery of squamous cell carcinoma of the head and neck
28. Prognostic significance of lymphatic spread in head and neck carcinomas: Therapeutic implications
29. TNM Classification of malignant tumors. A comparison between the new (1987) and old editions
30. Prognostic factors in laryngeal carcinoma. A multifactorial study of 416 cases
31. Prognostic factors of nasopharyngeal malignancy
32. Experience of the Curie Institute in treatment of cancer of the mobile tongue. Management of the neck nodes
33. Relationship between lymph nodal status and primary tumor control probability in tumors of the supraglottic larynx
34. Squamous cell carcinoma of the head and neck treated with radiation therapy: The impact of neck stage on local control
35. A multivariate primary tumour control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region: Clinical and treatment parameters as prognostic factors
36. Nasopharyngeal carcinoma: An evaluation of 209 patients
37. Neck nodes
38. Carcinoma of the tonsillar fossa. Significance of dose of irradiation and volume treated in the control of the primary tumor and metastatic neck nodes
39. The problem: Tumor radioresistance in clinical radiotherapy
40. Impact of cervical disease and its definitive radiotherapeutic management on survival: Experience in 2013 patients with squamous cell carcinomas of the oropharynx and pharyngolarynx
41. Squamous cell carcinoma of the head and neck treated with radiation therapy: The role of neck dissection for clinically positive neck nodes
42. The effectiveness of treatment of lymph nodes in cancers of the pyriform sinus and supraglottis
43. A randomized trial of adjuvant therapy in head and neck cancer
44. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous cell carcinoma of the head and neck
45. Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer